We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AVTE

Price
2.66
Stock movement up
+0.08 (3.10%)
Company name
Aerovate Therapeutics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
76.90M
Ent value
56.25M
Price/Sales
565.45
Price/Book
0.96
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-90.15%
3 year return
-45.27%
5 year return
-
10 year return
-
Last updated: 2025-04-11

DIVIDENDS

AVTE does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales565.45
Price to Book0.96
EV to Sales413.62

FINANCIALS

Per share

Loading...
Per share data
Current share count28.91M
EPS (TTM)-2.93
FCF per share (TTM)-2.60

Income statement

Loading...
Income statement data
Revenue (TTM)136.00K
Gross profit (TTM)52.00K
Operating income (TTM)-90.26M
Net income (TTM)-84.61M
EPS (TTM)-2.93
EPS (1y forward)-0.47

Margins

Loading...
Margins data
Gross margin (TTM)38.24%
Operating margin (TTM)-66366.91%
Profit margin (TTM)-62213.97%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash31.11M
Net receivables0.00
Total current assets90.61M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets90.96M
Accounts payable908.00K
Short/Current long term debt540.00K
Total current liabilities10.31M
Total liabilities10.47M
Shareholder's equity80.49M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-74.95M
Capital expenditures (TTM)64.00K
Free cash flow (TTM)-75.01M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-105.12%
Return on Assets-93.02%
Return on Invested Capital-104.52%
Cash Return on Invested Capital-92.66%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open2.58
Daily high2.82
Daily low2.58
Daily Volume1.03M
All-time high30.75
1y analyst estimate2.33
Beta1.00
EPS (TTM)-2.93
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
AVTES&P500
Current price drop from All-time high-91.35%-12.89%
Highest price drop-95.41%-56.47%
Date of highest drop18 Jun 20249 Mar 2009
Avg drop from high-47.21%-11.07%
Avg time to new high63 days12 days
Max time to new high325 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
AVTE (Aerovate Therapeutics Inc) company logo
Marketcap
76.90M
Marketcap category
Small-cap
Description
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Employees
51
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...